The Danish Health Authority temporarily suspends the use of the Oxford-AstraZeneca vaccine for two weeks as a "precaution" following reports that some vaccinated people had experienced blood clots, causing one person to die after receiving the vaccine. It has not been determined whether there is a link between the vaccine and the clots. Norway and Iceland have also suspended their use of the vaccine.
Danish Health Authority temporarily suspends the use of Oxford-AstraZeneca vaccine for two weeks as "precaution" following reports that some vaccinated people had experienced blood clots, thus one person died after receive the vaccine. But, it cannot concludes whether there is a link between both.
Danish Health Authority temporarily suspends the use of theOxford-AstraZeneca vaccine for two weeks as a"precaution" following reports that some vaccinated people had experienced blood clots, causing one person todie after receiving the vaccine. It hasnot beendetermined whether there is a link between thevaccineandtheclots.NorwayandIcelandalsosuspendedtheiruseofthevaccineaftertherevelation.
TheDanish Health Authority temporarily suspends the use of the Oxford-AstraZeneca vaccine for two weeks as a "precaution" following reports that some vaccinated people had experienced blood clots, causing one person to die after receiving the vaccine. It has not been determined whether there is a link between the vaccine and the clots. Norway and Iceland havealso suspended their use of the vaccine.
